A legal alert from three Harris Beach Murtha attorneys was one of the 15 most read FDA-related alerts published on JD Supra in 2025.

Attorneys Judi Abbott Curry, Marina Plotkin and Megan Pollastro, all members of the firm’s Medical and Life Sciences Industry Team, wrote the legal alert, which discussed how some popular weight management drugs were no longer on the Food and Drug Administration’s shortage list and how compounding pharmacies must discontinue creating copies of the drugs, something permitted by Congress in the case of drug shortages.

J.D. Supra noted in a recent year-end article entitled “The Year at the FDA – 2025 Popular Reads on JD Supra” that the alert was one of the top 15 most popular FDA-related reads on its site in 2025. JD Supra is an online platform that publishes business and legal intelligence, commentary and analysis from leading law firms. It regularly scrapes Harris Beach Murtha’s website for information that might be of interest to its audience of legal professionals, business leaders and the media.

“GLP-1 Weight-Loss Drugs Off Shortage List; Deadlines to Stop Compounding” can be read on the JD Supra site or on Harris Beach Murtha’s website.